Detalles de la búsqueda
1.
Rate of COVID-19 vaccination among patients with cancer who tested positive for severe acute respiratory syndrome-coronavirus 2: Analysis of the American Society of Clinical Oncology Registry.
Cancer
; 129(11): 1752-1762, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36920457
2.
Initial Results from Mobile Low-Dose Computerized Tomographic Lung Cancer Screening Unit: Improved Outcomes for Underserved Populations.
Oncologist
; 25(5): e777-e781, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31771991
3.
Targeted Therapy for Mutation-Driven Metastatic Non-Small-Cell Lung Cancer: Considerations for ALK-Rearranged Tumors.
Oncology (Williston Park)
; 33(4): 152-5, 2019 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30990569
4.
New targets and new mechanisms in lung cancer.
Oncology (Williston Park)
; 27(5): 396-404, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25184262
5.
Lorlatinib Tolerability and Association With Clinical Outcomes in Patients With Advanced ALK- or ROS1-Rearranged NSCLC: A Brief Report.
JTO Clin Res Rep
; 4(8): 100546, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37644967
6.
Full Dose SBRT in Combination With Mediastinal Chemoradiation for Locally Advanced, Non-Small Cell Lung Cancer: A Practical Guide for Planning, Dosimetric Results From a Phase 2 Study, and a Treatment Planning Guide for the Phase 3 NRG Oncology LU-008 Trial.
Pract Radiat Oncol
; 13(6): 531-539, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37406774
7.
Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non-Small Cell Lung Cancer: The Piedmont Study.
Clin Cancer Res
; 29(16): 3203-3213, 2023 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37233991
8.
Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapy.
NPJ Precis Oncol
; 7(1): 34, 2023 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36973365
9.
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.
J Clin Oncol
; 41(33): 5140-5150, 2023 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37561967
10.
Landscape and clinical impact of metabolic alterations in non-squamous non-small cell lung cancer.
Transl Lung Cancer Res
; 11(12): 2464-2476, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36636422
11.
Impact of a Clinical Genomics Program on Trial Accrual for Targeted Treatments: Practical Approach Overcoming Barriers to Accrual for Underserved Patients.
JCO Clin Cancer Inform
; 6: e2200011, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35839431
12.
Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO Registry.
JCO Oncol Pract
; 18(4): e426-e441, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34694907
13.
Defining comprehensive biomarker-related testing and treatment practices for advanced non-small-cell lung cancer: Results of a survey of U.S. oncologists.
Cancer Med
; 11(2): 530-538, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34921524
14.
The utilization of immunotherapy with radiation therapy in lung cancer: a narrative review.
Transl Cancer Res
; 10(5): 2596-2608, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35116573
15.
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Washout Period and Concomitant Medication Work Group.
Clin Cancer Res
; 27(9): 2400-2407, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33563635
16.
Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial.
Clin Lung Cancer
; 22(1): 6-15.e4, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33097414
17.
Assessing an ASCO Decision Aid for Improving the Accuracy and Attribution of Serious Adverse Event Reporting From Investigators to Sponsors.
J Oncol Pract
; 15(12): e1050-e1065, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31647695
18.
Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement.
J Clin Oncol
; 37(1): 72-80, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30339040
19.
Expanding the Multidisciplinary Team in Prediagnostic Care of Lung Cancer: How Else Can We Improve Time to Targeted Treatment in Metastatic Non-Small-Cell Lung Cancer?
JCO Oncol Pract
; 19(9): 694-696, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37607326
20.
Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statement.
J Immunother Cancer
; 6(1): 108, 2018 10 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30340549